59.57 -1.71 (-2.79%)
After hours: 5:13PM EDT
|Bid||61.08 x 1000|
|Ask||61.09 x 900|
|Day's Range||60.32 - 61.28|
|52 Week Range||54.17 - 73.13|
|Beta (3Y Monthly)||0.83|
|PE Ratio (TTM)||11.90|
|Earnings Date||May 1, 2019|
|Forward Dividend & Yield||1.64 (2.75%)|
|1y Target Est||68.60|
The top beer stocks have a market cap exceeding $2 billion and are trading on leading American stock exchanges. Here are the top beer stocks of 2018.
The maker of Sam Adams has successfully diversified into hard cider and spiked seltzer and tea. But there is little upside left in its shares as bigger rivals move in.
Ah, the magic of analyst ratings! After a tough month in April, cannabis firm Hexo (NYSEAmerican:HEXO) suddenly reversed course after Bank of America analyst Christopher Carey initiated coverage. Sizing up the risk and reward profile, Carey assigned a "buy" rating on Hexo stock with a $10 price target.Source: Shutterstock The news couldn't have come at a better time. While cannabis stocks offer tremendous upside because they essentially materialize an industry that previously never existed, they're also incredibly volatile. Because this is an unprecedented sector, many investors are unsure how to approach a company like HEXO.As such, I mentioned earlier that I liked Hexo stock, even compared to relative heavyweight Aurora Cannabis (NYSE:ACB). Unfortunately, the aforementioned volatility in cannabis stocks disproportionately impacted HEXO, sending my recommendation toward a quick grave. But thanks to Carey, this bad boy gained nearly 12% on Wednesday.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks to Buy for Spring Season Growth Of course, by the time that you're reading this, this dramatic burst in Hexo stock is in the past. Do newcomers still have a chance in riding this promising, but wild bull? Underappreciated Elements Support Hexo StockThe best way I can characterize Hexo stock is as a diamond in the rough. I believe the organization has the right components in place to make a solid run. However, the credibility issues that stymie virtually all cannabis stocks will pressure HEXO. At the end of the day, it comes down to your risk tolerance.But if you're willing to take that leap, Carey argues that this weed play deserves your attention. Primarily, HEXO stock is undervalued relative to its peers. Of course, in the marijuana sector, "undervalued" is an extremely relative term. That said, many cannabis stocks have hit nosebleed levels. Therefore, HEXO at least on paper provides some assurance of future room for growth.Next, the BofA analyst mentioned that Hexo stock is levered toward a "de-risked" Canadian cannabis market. Although I wouldn't use that term specifically, I see his point. Our northern neighbors paved the way for other western and developed nations to adopt tolerant policies. While this broader dynamic is building out, management has time to hone its craft.Finally, Carey mentioned "value-add partnerships" that go beyond the scope of Hexo's existent relationship with Molson Coors Brewing (NYSE:TAP). I agree. Cannabis stocks can branch out into subsegments of the broader categories of recreational and medicinal usage. However, let's not gloss over the Molson partnership as it holds a significant key for growth.Naturally, the idea here is for Hexo and Molson to developed cannabidiol (CBD)-infused drinks. Now, CBD itself is a tailwind for the industry as it offers non-psychoactive exposure to the cannabis plant. In other words, it's a lot easier to introduce people to weed through a drink rather than a joint. Upgrade Suggests Rising Credibility for Cannabis StocksIndeed, Hexo's Molson partnership has advantages over an expected synergy like Cronos Group (NASDAQ:CRON) and Altria Group (NYSE:MO). I don't think I can ever get my parents to smoke marijuana. But to drink it in a form that won't get them stoned? That's infinitely more palatable and more socially acceptable.Invariably, that had to enter BofA's thinking process when deciding to go bullish on Hexo stock. But just the fact that the big bank is even considering cannabis stocks is a major sign. It gives the industry significant credibility, and it suggests a very viable environment in the future.While we here in the U.S. have also warmed to varying degrees of legalization, most banks won't finance cannabis-related businesses. Why? Because it comes down to that nasty roadblock called Schedule I. Despite individual state laws, cannabis falls under strict federal guidelines.Sure, we've made progress in this department, too. For instance, the 2018 farm bill won consensus at a time when bipartisanship no longer exists. And major conservative figures have more or less voiced support for full legalization.Nevertheless, that Schedule I classification remains on the books for marijuana. Unless the federal government officially extinguishes it, most banks won't touch cannabis stocks. * 5 Dividend Stocks Perfect for Retirees And while BofA isn't necessarily diving into the sector with open arms, it's essentially giving you the green light to do so. Look, Hexo stock is a risky play no matter how you cut it. But if you've got the nerve, I'd read between the lines.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Buy for Spring Season Growth * This Is How You Beat Back a Bear Market * 7 Dental Stocks to Buy That Will Make You Smile Compare Brokers The post If You Can Tolerate Risk, Hexo Stock Is a Buy appeared first on InvestorPlace.
The big shareholder groups in Molson Coors Brewing Company (NYSE:TAP) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their owners...
With its peak drinking season fast approaching, MillerCoors has launched the "Take Back Summer" campaign, which includes four Summer Shandy commercials that take place in various warm-weather leisure settings.
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of Molson Coors Brewing Company (“Molson Coors” or the “Company”) (TAP) breached their fiduciary duties to the Company and its shareholders. Following Molson Coors’ recent disclosure that it will restate its 2016 and 2017 financial statements, Molson Coors shares declined nearly 10 percent in value. If you are a Molson Coors shareholder, you may have legal claims against the Company.
NEW YORK, NY / ACCESSWIRE / April 16, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you ...
LOS ANGELES, CA / ACCESSWIRE / April 16, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Molson Coors Brewing Company ...
NEW YORK, NY / ACCESSWIRE / April 15, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
NEW YORK, April 15, 2019 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following.
LOS ANGELES, CA / ACCESSWIRE / April 15, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Molson Coors Brewing Company ...
Global brewing giant Molson Coors Brewing Company (TAP) has recently attracted my attention as a cheap stock. This business has many of the traits I look for in an attractive investment. For example, the stock is trading at a forward price-earnings ratio of 11.7 and a price-book ratio of just under 1.
CEDARHURST, NY / ACCESSWIRE / April 15, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. ...
NEW YORK, NY / ACCESSWIRE / April 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
BOSTON, April 15, 2019 -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors of the important.
NEW YORK, April 15, 2019 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molson Coors Brewing Company (NYSE: TAP) from February.
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Molson Coors Brewing Company (“Molson Coors” or “the Company”) (NYSE: TAP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at firstname.lastname@example.org.
LOS ANGELES, CA / ACCESSWIRE / April 14, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Molson Coors Brewing Company ...
NEW YORK, NY / ACCESSWIRE / April 14, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you ...
NEWTOWN SQUARE, Pa., April 13, 2019 -- Kaskela Law LLC announces that shareholder class action lawsuits have been filed against Bristow Group Inc. (NYSE: BRS), Molson Coors.
The case, Mathes v. Molson Coors Brewing Company et al., No. 1:19-cv-01162, has been filed in the United States District Court for the Northern District of Illinois against the Company and certain of its officers.